Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
"On January 17, 2025, the Department of Health and Human Services (HHS) issued an update regarding HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors. The selected drugs include Ozempic, Trelegy Ellipta, and others, with negotiations planned for 2025 and prices set to take effect in 2027."
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
An OTP has been sent to your registered email address.